About Reiley Pharmaceuticals
Reiley Pharmaceuticals is a private company based in San Francisco, California. It has reported $4,530,523 raised in seven offerings on Form D since August 2014. Its chief executive is Donald Kiepert.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 31, 2024 | Jun 5, 2024 | $97,655of $247K target | 6 | $16,276 | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 12, 2022 | Oct 18, 2022amended Oct 19, 2022 | $100,000of $447K target | 2 | $50,000 | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 21, 2020 | Aug 3, 2020 | $1,052,868of $1.5M target | 27 | $38,995 | Equity, OptionsRule 506(b) | Form D ↗ |
| Not yet | Oct 24, 2019 | $0of $400K target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Nov 6, 2017 | Nov 7, 2017 | $1,200,000fully sold | 19 | $63,158 | EquityRule 506(b) | Form D ↗ |
| Dec 22, 2015 | Jan 6, 2016 | $1,100,000of $2.5M target | 20 | $55,000 | EquityRule 506(b) | Form D ↗ |
| Aug 15, 2014 | Aug 29, 2014 | $980,000of $1.2M target | 15 | $65,333 | EquityRule 506(b) | Form D ↗ |
| Total, seven offerings | $4,530,523 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Reiley Pharmaceuticals's Form D filed Jun 5, 2024.
Earlier filings also listed Mark Reiley (promoter, last listed Oct 2019).